Susquehanna Fundamental Investments, LLC Nkarta, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$5.59 - $15.71 $407,499 - $1.15 Million	72,898 New	72,898 $788 Million
Q3 2022 Nov 14, 2022	SELL	$12.27 - $18.39 $367,633 - $551,001	-29,962 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.79 - $26.88 $86,946 - $182,730	-6,798 Reduced 18.49%	29,962 $460,000
Q3 2021 Nov 15, 2021	BUY	$26.67 - $38.76 $980,389 - $1.42 Million	36,760 New	36,760 $1.02 Million
Q2 2021 Aug 11, 2021	SELL	$23.94 - $36.68 $193,890 - $297,071	-8,099 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$23.52 - $47.9 $190,488 - $387,942	8,099 New	8,099 $243,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.